- Home
- QNRX vs PETZ Comparison
QNRX vs PETZ Comparison
Compare QNRX & PETZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QNRX | PETZ |
|---|---|---|
| Founded | 2018 | 2002 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Steel/Iron Ore |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6M | 11.5M |
| IPO Year | 2023 | 2017 |
Fundamental Metrics
Financial Performance| Metric | QNRX | PETZ |
|---|---|---|
| Price | $4.20 | $1.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 34.2K | ★ 822.2K |
| Earning Date | 05-07-2026 | 04-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $6.89 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.10 | $0.81 |
| 52 Week High | $41.80 | $1.83 |
Technical Indicators
Market Signals| Indicator | QNRX | PETZ |
|---|---|---|
| Relative Strength Index (RSI) | 33.91 | 66.71 |
| Support Level | N/A | $0.98 |
| Resistance Level | $6.84 | $1.68 |
| Average True Range (ATR) | 0.49 | 0.17 |
| MACD | 0.03 | 0.05 |
| Stochastic Oscillator | 8.17 | 60.12 |
Price Performance
Historical ComparisonAbout QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
About PETZ TDH Holdings Inc.
TDH Holdings Inc currently focus on commercial real estate management. The company has determined that it has only one operating segment which is commercial real estate leasing operations. The company has presence in China and United States of which majority of revenue comes from China.